ArticleRare diseases (Austin, Tex.)2014

Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.

Shuling Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.